Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 06/24/16

    • 30-Day SEC Yield1

      1.89%
    • Total Net Assets

      $249.3M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2016
  • Portfolio Composition (%)
    as of 06/24/16

    • % of Net Assets
    • Stocks

      99.85
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.15
  • Download All HoldingsDaily Holdings (%) as of 06/24/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    114,042
    13,186,6765.29
    Merck & Co Inc
    MRK US
    229,190
    12,807,1375.14
    Abbvie Inc
    ABBV US
    213,931
    12,805,9105.14
    Pfizer Inc
    PFE US
    374,636
    12,726,3855.11
    Bristol-Myers Squibb Co
    BMY US
    179,894
    12,702,3155.10
    Glaxosmithkline Plc
    GSK US
    310,654
    12,674,6835.08
    Novartis Ag
    NVS US
    162,256
    12,509,9385.02
    Sanofi
    SNY US
    318,983
    12,264,8964.92
    Allergan Plc
    AGN US
    52,834
    11,925,6904.78
    Eli Lilly & Co
    LLY US
    158,661
    11,793,2724.73
    Novo Nordisk A/S
    NVO US
    230,954
    11,792,5114.73
    Abbott Laboratories
    ABT US
    305,455
    11,579,7994.65
    Zoetis Inc
    ZTS US
    245,312
    11,409,4614.58
    Mckesson Corp
    MCK US
    63,306
    11,209,5934.50
    Astrazeneca Plc
    AZN US
    400,988
    11,171,5264.48
    Mylan Nv
    MYL US
    255,542
    11,131,4104.47
    Teva Pharmaceutical Industries Ltd
    TEVA US
    220,140
    11,009,2014.42
    Shire Plc
    SHPG US
    63,012
    10,461,8824.20
    Amerisourcebergen Corp
    ABC US
    128,477
    9,692,3053.89
    Perrigo Co Plc
    PRGO US
    102,053
    9,287,8443.73
    Valeant Pharmaceuticals International I
    VRX US
    212,797
    4,313,3951.73
    Jazz Pharmaceuticals Plc
    JAZZ US
    27,889
    3,845,8931.54
    Mallinckrodt Plc
    MNK US
    54,072
    3,026,4101.21
    Akorn Inc
    AKRX US
    66,079
    1,835,0140.74
    Endo International Plc
    ENDP US
    115,729
    1,718,5760.69
    Other/Cash
    --
    --
    376,4090.15
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.